Avon allocates $250,000 for COVID-19 Community Relief Grants
Application available to nonprofit organizations providing relief to Avon residents and businesses suffering financially
On April 9th, the Avon Town Council allocated $250,000 in Community Relief Grant funding to help Avon residents and businesses who have been affected by the COVID-19 pandemic. Avon Community Relief Grants are available to organizations who directly impact Avon residents with financial relief in the areas of food, shelter and health. Council directed staff to form an Ad Hoc Review Committee to review applications in a similar fashion to the Town’s Community Grant Program, which provides annual grant funding to eligible nonprofit organizations.
Applications for the Avon Community Relief Grants are available at avon.org/covid-19. To qualify for funding consideration, applicants must be an existing nonprofit 501(c)(3) organization whose mission aligns with the intent of the Avon Community Relief Grant program to provide immediate assistance to individuals most in need. Applicants will need to provide an overview of the request, how the relief funds will be distributed, budget documentation, and measurement mechanisms. The Town of Avon has already received a request from the Eagle Valley Community Foundation for $100,000 to continue providing pop up community market services in three Avon neighborhoods.
Additionally, the Avon Town Council approved $50,000 in funding for a meal voucher program, which supports local Avon restaurants. The Town has purchased $20 meal vouchers from Avon restaurants for its furloughed employees, as well as essential staff who continue to report to work. This program will be expanded to provide meal vouchers to Avon residents and full-time staff.
For more information on Avon Community Relief Grants, please contact Communications & Marketing Manager Elizabeth Wood at (970) 748-4087 or email@example.com. More information on these initiatives and other community-related COVID-19 resources is available at avon.org/covid-19.